Healthcare ETFs Compared Fidelity vs iShares | Business and Finance News

Two healthcare ETFs face off: Fidelity’s broad-spectrum fund vs. iShares’ concentrated pharma play. Fidelity wins on cost (0.08% vs. 0.37%) and diversification, covering 300+ healthcare holdings from devices to drugs. iShares delivers hotter recent returns (60% vs. 33.7% in one year) but bets big on giants like Eli Lilly and Johnson & Johnson — exposing you to higher risk. For most investors, Fidelity’s balanced, low-cost approach is smarter long-term, even if iShares shines short-term. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/00712b016ae652bd